Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer

European Urology

Volumn 67, Issue 1, 2015, Pages 44-50

  Womble, Paul R ^a   Montie, James E ^a   Ye, Zaojun ^a   Linsell, Susan M ^a   Lane, Brian R ^b   Miller, David C ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Active surveillance; Low risk prostate cancer; Quality improvement collaborative

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACTIVE SURVEILLANCE; ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURGERY; COHORT ANALYSIS; DISEASE SURVEILLANCE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; UNITED STATES; BIOPSY; BLOOD; COMMUNITY CARE; PATHOLOGY; PROSTATE; PROSTATIC NEOPLASMS; REGISTER; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; UROLOGY; UTILIZATION; WATCHFUL WAITING;

AGED; BIOPSY; COMMUNITY HEALTH SERVICES; HUMANS; MALE; MICHIGAN; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGISTRIES; RISK ASSESSMENT; UROLOGY; WATCHFUL WAITING;

EID: 84921778323     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.08.024     Document Type: Article

References (22)

1. M.R. Cooperberg, J.M. Broering, and P.R. Carroll Time trends and local variation in primary treatment of localized prostate cancer J Clin Oncol 28 2010 1117 1123
2. D.C. Miller, S.B. Gruber, B.K. Hollenbeck, J.E. Montie, and J.T. Wei Incidence of initial local therapy among men with lower-risk prostate cancer in the United States J Natl Cancer Inst 98 2006 1134 1141
3. B.L. Jacobs, Y. Zhang, T.A. Skolarus, and B.K. Hollenbeck Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse Health Aff (Millwood) 31 2012 750 759
4. T.J. Daskivich, K. Chamie, and L. Kwan Overtreatment of men with low-risk prostate cancer and significant comorbidity Cancer 117 2011 2058 2066
5. V.A. Moyer U.S. Preventive Services Task Force Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 157 2012 120 134
6. L.J. Esserman, I.M. Thompson Jr., and B. Reid Overdiagnosis and overtreatment in cancer: an opportunity for improvement JAMA 310 2013 797 798
7. P.R. Carroll Early stage prostate cancer - do we have a problem with over-detection, overtreatment or both? J Urol 173 2005 1061 1062
8. L. Klotz Cancer overdiagnosis and overtreatment Curr Opin Urol 22 2012 203 209
9. S.R. Harlan, M.R. Cooperberg, and E. Elkin Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE J Urol 170 2003 1804 1807
10. X. Wu, V.W. Chen, and P.A. Andrews Initial treatment patterns for clinically localized prostate cancer and factors associated with the treatment in Louisiana J La State Med Soc 157 2005 188 194
11. C.P. Filson, F.R. Schroeck, Z. Ye, J.T. Wei, B.K. Hollenbeck, and D.C. Miller Variation in use of active surveillance among men undergoing expectant management for early stage prostate cancer J Urol 192 2014 75 81
12. J.M. Mitchell Urologists' use of intensity-modulated radiation therapy for prostate cancer N Engl J Med 369 2013 1629 1637
13. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
14. P.R. Womble, M.W. Dixon, and S.M. Linsell Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative J Urol 191 2014 1787 1792
15. C.B. Riedinger, P.R. Womble, and S.M. Linsell Variation in prostate cancer detection rates in a statewide quality improvement collaborative J Urol 192 2014 373 378
16. F.R. Schroeck, S.R. Kaufman, and B.L. Jacobs The impact of technology diffusion on treatment for prostate cancer Med Care 51 2013 1076 1084
17. T.J. Wilt, M.K. Brawer, and K.M. Jones Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203 213
18. A. Bill-Axelson, L. Holmberg, and H. Garmo Radical prostatectomy or watchful waiting in early prostate cancer N Engl J Med 370 2014 932 942
19. L.F. Newcomb, J.D. Brooks, and P.R. Carroll Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository Urology 75 2010 407 413
20. A.C. Reese, P. Landis, M. Han, J.I. Epstein, and H.B. Carter Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis J Urol 190 2013 2033 2038
21. L. Stamatakis, M.M. Siddiqui, and J.W. Nix Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer Cancer 119 2013 3359 3366
22. D.W. Lin, L.F. Newcomb, and E.C. Brown Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study Clin Cancer Res 19 2013 2442 2450